4-Fluorosulfonylpiperidines: Selective 5-HT2A ligands for the treatment of insomnia
作者:L. Rebecca Fish、Myra T. Gilligan、Alexander C. Humphries、Magnus Ivarsson、Tammy Ladduwahetty、Kevin J. Merchant、Desmond O’Connor、Smita Patel、Elisabeth Philipps、Hugo M. Vargas、Peter H. Hutson、Angus M. MacLeod
DOI:10.1016/j.bmcl.2005.05.104
日期:2005.8
Incorporation of fluorine at the 4-position of an existing series of sulfonyl piperidine 5-HT2A antagonists gave compounds with increased selectivity over the IKr potassium channel. This work led to the identification of 3b, a compound that gave no increase in QT(c) in the anesthetized dog up to plasma levels as high as 148 mu M. Furthermore, 3b has been shown to increase slow-wave sleep bout duration and to decrease the number of awakenings in rats, indicating the potential utility of 5-HT2A antagonists in the treatment of insomnia. (c) 2005 Elsevier Ltd. All rights reserved.